Veracyte, Inc.

VCYT

$34.61

Name : Veracyte, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $2,835,324,160.00

EPSttm : 0.34

Veracyte, Inc.

$34.61

3.97%

$1.43

Float Short %

11.87

Margin Of Safety %

-16

Put/Call OI Ratio

0.15

EPS Next Q Diff

-0.07

EPS Last/This Y

1.11

EPS This/Next Y

0.01

Price

34.62

Target Price

42.11

Analyst Recom

1.55

Performance Q

27.81

Relative Volume

0.53

Beta

2.16

Ticker: VCYT

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	VCYT	32.47	0.20	0.16	1731
2025-09-09	VCYT	31.99	0.20	0.12	1738
2025-09-10	VCYT	30.9	0.20	0.80	1756
2025-09-11	VCYT	31.86	0.20	0.71	1756
2025-09-12	VCYT	30.88	0.19	2.15	1747
2025-09-15	VCYT	31.87	0.21	0.64	1787
2025-09-16	VCYT	32.27	0.21	0.33	1808
2025-09-17	VCYT	31.83	0.21218206157965	0.03448275862069	1811
2025-09-18	VCYT	33.24	0.21	3.00	1816
2025-09-22	VCYT	33.95	0.17	0.09	1429
2025-09-23	VCYT	34.18	0.17	2.25	1441
2025-09-24	VCYT	32.65	0.16	1.25	1434
2025-09-25	VCYT	32.82	0.17	0.00	1440
2025-09-26	VCYT	33.43	0.16	999.99	1442
2025-09-29	VCYT	33.64	0.16	0.25	1436
2025-09-30	VCYT	34.34	0.16	0.00	1437
2025-10-01	VCYT	36.22	0.16	0.00	1429
2025-10-02	VCYT	35.61	0.16	0.00	1459
2025-10-03	VCYT	36.01	0.15	0.00	1468
2025-10-06	VCYT	36.04	0.15	0.00	1482
2025-10-07	VCYT	34.63	0.15	999.99	1492
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	VCYT	32.46	-3.5	89.7	1.43
2025-09-09	VCYT	31.97	-3.5	87.5	1.43
2025-09-10	VCYT	30.81	-3.5	84.6	1.43
2025-09-11	VCYT	31.86	-3.5	94.0	1.43
2025-09-12	VCYT	30.88	-3.5	85.4	1.43
2025-09-15	VCYT	31.88	-3.5	93.8	1.43
2025-09-16	VCYT	32.28	-3.5	91.2	1.43
2025-09-17	VCYT	31.83	-3.5	87.7	1.43
2025-09-18	VCYT	33.25	-3.5	95.4	1.43
2025-09-19	VCYT	34.12	-3.5	93.1	1.43
2025-09-22	VCYT	33.93	-3.5	88.8	1.43
2025-09-23	VCYT	34.18	-3.5	90.5	1.43
2025-09-24	VCYT	32.63	-3.5	83.7	1.43
2025-09-25	VCYT	32.82	-3.5	90.1	1.43
2025-09-26	VCYT	33.44	-3.5	92.0	1.43
2025-09-29	VCYT	33.64	-3.5	90.3	1.43
2025-09-30	VCYT	34.31	-3.5	92.3	1.43
2025-10-01	VCYT	36.22	-3.5	96.9	1.43
2025-10-02	VCYT	35.62	-3.5	87.4	1.43
2025-10-03	VCYT	36.01	-3.5	90.9	1.43
2025-10-06	VCYT	36.05	-3.5	91.1	1.43
2025-10-07	VCYT	34.62	-3.5	84.4	1.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	VCYT	-1.48	7.01	10.61
2025-09-09	VCYT	-1.48	7.01	10.61
2025-09-10	VCYT	-1.48	7.01	10.61
2025-09-11	VCYT	-1.09	7.01	10.46
2025-09-12	VCYT	-1.09	7.01	10.46
2025-09-15	VCYT	-1.10	7.07	10.46
2025-09-16	VCYT	-1.10	7.07	10.46
2025-09-17	VCYT	-1.10	7.07	10.46
2025-09-18	VCYT	-1.10	7.07	10.46
2025-09-19	VCYT	-1.10	7.07	10.46
2025-09-22	VCYT	-1.10	7.08	10.46
2025-09-23	VCYT	-1.22	7.08	10.46
2025-09-24	VCYT	-1.22	7.08	10.46
2025-09-25	VCYT	-1.22	7.08	11.87
2025-09-26	VCYT	-1.22	7.08	11.87
2025-09-29	VCYT	-1.22	7.06	11.87
2025-09-30	VCYT	-1.22	7.06	11.87
2025-10-01	VCYT	-1.22	7.06	11.87
2025-10-02	VCYT	-1.22	7.06	11.87
2025-10-03	VCYT	-2.65	7.06	11.87
2025-10-06	VCYT	-2.65	8.06	11.87
2025-10-07	VCYT	-3.09	8.06	11.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.44

Avg. EPS Est. Current Quarter

0.32

Avg. EPS Est. Next Quarter

0.37

Insider Transactions

-3.09

Institutional Transactions

8.06

Beta

2.16

Average Sales Estimate Current Quarter

124

Average Sales Estimate Next Quarter

131

Fair Value

29.11

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

59.8

Max Drawdown 5-Year %

-81.2

Target Price

42.11

P/E

104.03

Forward P/E

23.73

PEG

1.42

P/S

5.68

P/B

2.23

P/Free Cash Flow

32.43

EPS

0.33

Average EPS Est. Cur. Y

1.43

EPS Next Y. (Est.)

1.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.5

Relative Volume

0.53

Return on Equity vs Sector %

-23

Return on Equity vs Industry %

-8.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

84.4

Veracyte, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 824

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

stock quote shares VCYT – Veracyte, Inc. Stock Price stock today

news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VCYT – Veracyte, Inc. yahoo finance google finance

stock history VCYT – Veracyte, Inc. invest stock market

stock prices VCYT premarket after hours

ticker VCYT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VCYT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y